| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| H795140 | MACKLIN | 4-(4-(4-氯苯基)-4-羟基哌啶-1-基)-1-(4-氟苯基)丁-1-酮 | 10mM in DMSO | 366元/1ml; | 展开 |
|
| H811298 | MACKLIN | 4-(4-(4-氯苯基)-4-羟基哌啶-1-基)-1-(4-氟苯基)丁-1-酮 | 98% | 180元/1g; 732元/5g; 2450元/25g; | 展开 |
|
| H0912 | TCI | Haloperidol | >98.0%(T)(HPLC) | 835元/5G; 1730元/25G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C21H23ClFNO2 = 375.87 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 331267 | | PubChem物质ID | 87571270 | | SDBS (AIST Spectral DB) | 14024 | | Merck Index (14) | 4598 | | MDL编号 | MFCD00051423 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Solubility in Acetic acid | almost transparency | | Melting point | 150.0 to 153.0 ℃ |
物性(参考值) | 熔点 | 152 ℃ | | 水溶性 | 不溶 | | 溶解性(可溶于) | 丙酮,氯仿,苯 |
安全信息 | 图形或危害标志 |   | | 信号词 | 危险 | | 危险性说明 | H301 : 吞咽会中毒。 H315 : 造成皮肤刺激。 H319 : 造成严重眼刺激。 H360 : 可能对生育能力或胎儿造成伤害。 H362 : 可能对母乳喂养的儿童造成伤害。 H370 : 会损害器官。 H372 : 长期或反复接触会对器官造成损害。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P263 : 怀孕/ 哺乳期间避免接触。 P260 : 不要吸入粉尘/ 烟/ 气体/ 烟雾/ 蒸气/ 喷雾。 P270 : 使用本产品时不要进食、饮水或吸烟。 P202 : 在阅读并明了所有安全措施前切勿搬动。 P201 : 使用前取得专用说明。 P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P302 + P352 : 如皮肤沾染:用水充分清洗。 P337 + P313 : 如仍觉眼刺激:求医/就诊。 P305 + P351 + P338 : 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P308+P311 : 如接触到或有疑虑:呼叫急救中心/医生。 P362+P364 : 脱掉沾污的衣服,清洗后方可重新使用。 P332 + P313 : 如发生皮肤刺激:求医/就诊。 P301 + P310 + P330 : 如误吞咽:立即呼叫急救中心/医生。漱口。 P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | III | | 监管条件代码(*) | |
|
| Y0001518 | | Haloperidol for peak identification | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 20 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C21H23ClFNO2 | | 分子量 | 375.86 | | MDL编号 | MFCD00051423 | | PubChem化学物质编号 | 329831469 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3 | | InChI | 1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 | | InChI key | LNEPOXFFQSENCJ-UHFFFAOYSA-N | | Gene Information | human ... HTR2A(3356) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H315 - H317 - H319 - H335 - H361 | | 预防措施声明 | P201 - P280 - P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Acute Tox. 3 Oral - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0001517 | | Haloperidol for system suitability | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C21H23ClFNO2 | | 分子量 | 375.86 | | MDL编号 | MFCD00051423 | | PubChem化学物质编号 | 329831468 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3 | | InChI | 1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 | | InChI key | LNEPOXFFQSENCJ-UHFFFAOYSA-N | | Gene Information | human ... HTR2A(3356) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H315 - H317 - H319 - H335 - H361 | | 预防措施声明 | P201 - P202 - P280 - P301 + P310 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Acute Tox. 3 Oral - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| H0100000 | | Haloperidol | European Pharmacopoeia (EP) Reference Standard | 1259.15元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 60 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C21H23ClFNO2 | | 分子量 | 375.86 | | MDL编号 | MFCD00051423 | | PubChem化学物质编号 | 329815103 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3 | | InChI | 1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 | | InChI key | LNEPOXFFQSENCJ-UHFFFAOYSA-N | | Gene Information | human ... HTR2A(3356) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H315 - H317 - H319 - H335 - H361 | | 预防措施声明 | P201 - P280 - P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Acute Tox. 3 Oral - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| H1512 | Sigma-Aldrich | Haloperidol | powder | 1521.75元/5 G; 2266.84元/10 G; 4880.63元/25 G; | 展开 |
产品说明 应用 氟哌啶醇已:
- 用在乙醇中,作为 Erg2p 抑制剂
- 通过肝细胞癌细胞来研究氟哌啶醇在细胞凋亡中的作用机制:Hep G2 和 Huh-7 细胞系
- 用于在受体内化测定
- 在杜氏培养基中用作抗精神病药物
包装 5, 10, 25 g in glass bottle 生化/生理作用 氟哌啶醇是丁酰苯类抗精神病药。也被归类为精神抑制药(强效镇静剂)。氟哌啶醇作为 D2、D3 和 D4 多巴胺受体拮抗剂,可引起帕金森病,对中枢神经系统也有负面影响。 特点和优势 该化合物出现在《受体分类和信号转导手册》的 钾通道 页。要浏览其他手册页, 单击此处 。 该化合物由 Johnson & Johnson 开发。如需浏览其他制药公司开发的化合物和批准的药物/候选药物列表,请点击此处。 其他说明 由斯克里普斯代谢组学中心独立生成的串联质谱数据可以以 PDF 格式查看或下载。 H1512.pdf 经测试的代谢产物见斯克里普斯代谢组学中心 METLIN 代谢产物数据库。要了解更多信息,请访问 sigma.com/metlin。 基本信息 | 经验(实验)分子式 | C21H23ClFNO2 | | 分子量 | 375.86 | | EC 号 | 200-155-6 | | MDL编号 | MFCD00051423 | | PubChem化学物质编号 | 24277917 | | NACRES | NA.77 |
产品性质 | 质量水平 | 200 | | 形式 | powder | | 颜色 | white | | 溶解性 | 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.39 mg/mL 0.1 M HCl: 3 mg/mL DMSO: soluble H2O: insoluble ethanol: soluble | | 创始人 | Johnson & Johnson | | SMILES string | OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3 | | InChI | 1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 | | InChI key | LNEPOXFFQSENCJ-UHFFFAOYSA-N | | Gene Information | human ... ABCB1(5243), ADRA1A(148), ADRA2A(150), ADRA2C(152), CHRM1(1128), DRD2(1813), DRD3(1814), DRD4(1815), EBP(10682), HRH1(3269), HTR2A(3356), HTR2C(3358), HTR7(3363), KCNH1(3756), KCNH2(3757), PRNP(5621) rat ... Adra1a(29412), Adra2a(25083), Chrm1(25229), Chrm2(81645), Drd1a(24316), Drd2(24318), Drd3(29238), Drd4(25432), Hrh1(24448), Htr1a(24473), Htr1b(25075), Htr2a(29595), Htr2c(25187), Oprs1(29336), Slc6a3(24898), Slc6a4(25553) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H315 - H317 - H319 - H335 - H361 | | 预防措施声明 | P201 - P280 - P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Acute Tox. 3 Oral - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP407 | | Haloperidol | British Pharmacopoeia (BP) Reference Standard | 2244.51元/150 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 150 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C21H23ClFNO2 | | 分子量 | 375.86 | | EC 号 | 200-155-6 | | MDL编号 | MFCD00051423 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3 | | InChI | 1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 | | InChI key | LNEPOXFFQSENCJ-UHFFFAOYSA-N | | Gene Information | human ... HTR2A(3356) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H315 - H317 - H319 - H335 - H361 | | 预防措施声明 | P201 - P261 - P264 - P280 - P301 + P310 + P330 - P304 + P340 + P312 | | 危险分类 | Acute Tox. 3 Oral - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| PHR1724 | Supelco | Haloperidol | Pharmaceutical Secondary Standard; Certified Reference Material | 2229.22元/400 MG; | 展开 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Haloperidol is a major tranquilizer that is indicated for the treatment of schizophrenia, mania and neurological disorders including hyperkinesia. 应用 These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. Haloperidol may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by high performance liquid chromatography (HPLC) and spectrophotometry techniques. 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAB7792 in the Documents slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C21H23ClFNO2 | | 分子量 | 375.86 | | EC 号 | 200-155-6 | | MDL编号 | MFCD00051423 | | PubChem化学物质编号 | 329823577 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | 包装 | pkg of 400 mg | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to BP 407 traceable to PhEur H0100000 traceable to USP 1303002 | | 储存温度 | 2-30℃ | | SMILES string | OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3 | | InChI | 1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 | | InChI key | LNEPOXFFQSENCJ-UHFFFAOYSA-N | | Gene Information | human ... HTR2A(3356) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H315 - H317 - H319 - H335 - H361 | | 预防措施声明 | P201 - P280 - P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Acute Tox. 3 Oral - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1303002 | USP | Haloperidol | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C21H23ClFNO2 | | 分子量 | 375.86 | | MDL编号 | MFCD00051423 | | PubChem化学物质编号 | 329749983 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3 | | InChI | 1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2 | | InChI key | LNEPOXFFQSENCJ-UHFFFAOYSA-N | | Gene Information | human ... HTR2A(3356) |
安全信息 | 象形图 |   | | 警示用语: | Danger | | 危险声明 | H301 - H315 - H317 - H319 - H335 - H361 | | 预防措施声明 | P201 - P280 - P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Acute Tox. 3 Oral - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| M04089 | Fluorochem | Haloperidol | 99% | 264元/1g; 1078元/5g; 3762元/25g; | 展开 |
基本信息 | CAS Number | 52-86-8 | | MDL Number | MFCD00051423 | | Melting Point | 152℃ |
安全信息 | 图形或危害标志 |   | | 危险性说明 | H301: Toxic if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: . P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see . on this label). P330: Rinse mouth. P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to local regulations.
|
|